PILOT STUDY OF SIROLIMUS IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Decaens, Thomas [1 ]
Luciani, Alain [2 ]
Itti, Emmanuel [3 ]
Hulin, Anne [4 ]
Hurtova, Monika [1 ]
Laurent, Alexis [5 ]
Cherqui, Daniel [5 ]
Malat, Ariane [1 ]
Duvoux, Christophe [1 ]
机构：
[1] Hop Henri Mondor, Dept Hepatol & Liver Transplantat, F-94010 Creteil, France
[2] Hop Henri Mondor, Dept Med Imaging, F-94010 Creteil, France
[3] Hop Henri Mondor, Dept Nucl Med, F-94010 Creteil, France
[4] Hop Henri Mondor, Dept Pharm, F-94010 Creteil, France
[5] Hop Henri Mondor, Dept Surg & Livar Transplantat, F-94010 Creteil, France
来源：
HEPATOLOGY | 2008年 / 48卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1453
引用
收藏
页码：953A / 953A
页数：1
相关论文
共 50 条
  • [1] Pilot study of sirolimus in cirrhotic patients with advanced hepatocellular carcinoma
    Decaens, T.
    Luciani, A.
    Itti, E.
    Hulin, A.
    Hurtova, M.
    Laurent, A.
    Cherqui, D.
    Mallat, A.
    Duvoux, C.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S13 - S13
  • [2] Pharmacokinetic study of sirolimus in cirrhotic patients with advanced hepatocellular carcinoma
    Decaens, T.
    Hulin, A.
    Hurtova, M.
    Luciani, A.
    Itti, E.
    Laurent, A.
    Cherqui, D.
    Mallat, A.
    Duvoux, C.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S144 - S144
  • [3] EGFR expression in advanced hepatocellular carcinoma (HCC): an autopsy study in cirrhotic patients
    Silva, F. A.
    Cassol, C. A.
    Goncalves, F. R.
    Wakamatsu, A.
    Cirqueira, C. S.
    Ressio, R. A.
    Alves, V. A. F.
    HISTOPATHOLOGY, 2010, 57 : 164 - 164
  • [4] Effects of the combined treatment with thalidomide, megestrol and interleukine-2 in cirrhotic patients with advanced hepatocellular carcinoma - A pilot study
    Cappa, FM
    Cantarini, MC
    Magini, G
    Zambruni, A
    Bendini, C
    Santi, V
    Bernardi, M
    Trevisani, F
    DIGESTIVE AND LIVER DISEASE, 2005, 37 (04) : 254 - 259
  • [5] Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma
    Decaens, Thomas
    Luciani, Alain
    Itti, Emmanuel
    Hulin, Anne
    Roudot-Thoraval, Francoise
    Laurent, Alexis
    Zafrani, Elie Serge
    Mallat, Ariane
    Duvoux, Christophe
    DIGESTIVE AND LIVER DISEASE, 2012, 44 (07) : 610 - 616
  • [6] Pilot study: rapamycin in advanced hepatocellular carcinoma
    Schoeniger-Hekele, M.
    Mueller, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (06) : 763 - 768
  • [7] Rebleeding does not affect prognosis of cirrhotic patients with advanced hepatocellular carcinoma
    Amitrano, L.
    Di Costanzo, G. G.
    Guardascione, M. A.
    Menchise, A.
    Martino, R.
    Balzano, A.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S89 - S89
  • [8] Pharmacokinetics of sirolimus in patients with hepatocellular carcinoma
    Andriamanana, I.
    Bourdaudhui, T.
    Gury, V.
    Chevalier, S.
    Faivre, S.
    Raymond, E.
    Decaens, T.
    Hulin, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 27 - 27
  • [9] Pharmacokinetics of sirolimus in patients with hepatocellular carcinoma
    Andriamanana, I
    Bourdaudhui, T.
    Gury, V
    Chevalier, S.
    Faivre, S.
    Raymond, E.
    Decaens, T.
    Hulin, A.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 547 - 547
  • [10] Expression of glycosaminoglycans in cirrhotic liver and hepatocellular carcinoma—a pilot study including etiology
    Gábor Tóth
    Domonkos Pál
    Simon Sugár
    Ilona Kovalszky
    Katalin Dezső
    Gitta Schlosser
    László Drahos
    Lilla Turiák
    Analytical and Bioanalytical Chemistry, 2022, 414 : 3837 - 3846
12345